News Release Details

GAITHERSBURG, Md., April 29, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company's senior management team will participate in the following investor conferences in May and June 2015.

• Credit Suisse Antibody Conference
  New York, NY
  May 6, 2015
  Presentation: 1:50PM Eastern
   
• Bank of America / Merrill Lynch 2015 Healthcare Conference
  Las Vegas, NV
  May 14, 2015
  Presentation: 3:00PM Eastern
   
• Jefferies 2015 Healthcare Conference
  New York, NY
  June 1-4, 2015
  Presentation day and time TBD

For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under "Investors."

About Emergent BioSolutions

Emergent BioSolutions is a global specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at http://www.emergentbiosolutions.com. Follow us on twitter: @emergentbiosolu.

CONTACT: Investor Contact:
         Robert G. Burrows
         Vice President, Investor Relations
         240-631-3280
         BurrowsR@ebsi.com

         Media Contact:
         Tracey Schmitt
         Vice President, Global Public Affairs
         and Corporate Responsibility
         240-631-3394
         SchmittT@ebsi.com